Recombinant Chimeric COVID-19 DC Vaccine

Recombinant Chimeric COVID-19 DC Vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.

The recombinant chimeric DC vaccine is a subunit-based vaccine candidate investigated for safety and effectiveness against SARS-CoV-2-induced pneumonia. With a better safety profile than inactivated and live-attenuated virus and virus-vector vaccines, the recombinant chimeric DC vaccine reduces the risk of virulence recovery, pre-existing anti-vector immunity, and incomplete viral inactivation.

As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.

Trade Name Recombinant Chimeric COVID-19 DC Vaccine
Generic Dendritic cells vaccine
Dendritic cells vaccine Other Names Recombinant chimeric COVID-19 DC vaccine, Recombinant chimeric COVID-19 epitope DC vaccine;
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Recombinant Chimeric COVID-19 DC Vaccine
Recombinant Chimeric COVID-19 DC Vaccine

Innovators Monograph

You find simplified version here Recombinant Chimeric COVID-19 DC Vaccine


*** Taking medicines without doctor's advice can cause long-term problems.
Share